ABSTRACT
PURPOSE: There is an unmet need for identifying novel biomarkers in Barrett's esophagus that could stratify patients with regards to neoplastic progression. We investigate the expression patterns of extracellular matrix (ECM) molecules in Barrett's esophagus and Barrett's esophagus-related neoplasia, and assess their value as biomarkers for the diagnosis of Barrett's esophagus-related neoplasia and to predict neoplastic progression. EXPERIMENTAL DESIGN: Gene-expression analyses of ECM matrisome gene sets were performed using publicly available data on human Barrett's esophagus, Barrett's esophagus-related dysplasia, esophageal adenocarcinoma (ADCA) and normal esophagus. Immunohistochemical expression of basement membrane (BM) marker agrin (AGRN) and p53 was analyzed in biopsies of Barrett's esophagus-related neoplasia from 321 patients in three independent cohorts. RESULTS: Differential gene-expression analysis revealed significant enrichment of ECM matrisome gene sets in dysplastic Barrett's esophagus and ADCA compared with controls. Loss of BM AGRN expression was observed in both Barrett's esophagus-related dysplasia and ADCA. The mean AGRN loss in Barrett's esophagus glands was significantly higher in Barrett's esophagus-related dysplasia and ADCA compared with non-dysplastic Barrett's esophagus (NDBE; P < 0.001; specificity = 82.2% and sensitivity = 96.4%). Loss of AGRN was significantly higher in NDBE samples from progressors compared with non-progressors (P < 0.001) and identified patients who progressed to advanced neoplasia with a specificity of 80.2% and sensitivity of 54.8%. Moreover, the combination of AGRN loss and abnormal p53 staining identified progression to Barrett's esophagus-related advanced neoplasia with a specificity and sensitivity of 86.5% and 58.7%. CONCLUSIONS: We highlight ECM changes during Barrett's esophagus progression to neoplasia. BM AGRN loss is a novel diagnostic biomarker that can identify patients with NDBE at increased risk of developing advanced neoplasia.
Subject(s)
Barrett Esophagus , Esophageal Neoplasms , Agrin/genetics , Agrin/metabolism , Barrett Esophagus/diagnosis , Barrett Esophagus/genetics , Barrett Esophagus/pathology , Biomarkers/analysis , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/genetics , Humans , Tumor Suppressor Protein p53ABSTRACT
Metastasis causes most cancer-related deaths, and one poorly understood aspect of metastatic cancer is the adaptability of cells from a primary tumor to create new niches and survive in multiple, different secondary sites. We used quantitative mass spectrometry to analyze the extracellular matrix (ECM), a critical component of metastatic niches, in metastases to the brain, lungs, liver, and bone marrow, all derived from parental MDA-MB-231 triple-negative breast cancer cells. Tumor and stromal cells cooperated in forming niches; stromal cells produced predominantly core, structural ECM proteins and tumor cells produced a diverse array of ECM-associated proteins, including secreted factors and modulators of the matrix. In addition, tumor and stromal cells together created distinct niches in each tissue. Downregulation of SERPINB1, a protein elevated in brain metastases, led to a reduction in brain metastasis, suggesting that some niche-specific ECM proteins may be involved in metastatic tropism. SIGNIFICANCE: Tumor and stromal cells together create distinct ECM niches in breast cancer metastases to various tissues, providing new insight into how tumor cells adapt to survive in different tissue environments.
Subject(s)
Bone Marrow Neoplasms/secondary , Brain Neoplasms/secondary , Extracellular Matrix/pathology , Liver Neoplasms/secondary , Lung Neoplasms/secondary , Triple Negative Breast Neoplasms/pathology , Bone Marrow/pathology , Brain/pathology , Cell Survival , Disease Progression , Down-Regulation , Female , Gene Expression Profiling , Gene Knockdown Techniques , Humans , Liver/pathology , Lung/pathology , Neoplastic Stem Cells/pathology , Proteomics , Serpins/genetics , Serpins/metabolism , Stromal Cells/pathology , Tumor Microenvironment , Xenograft Model Antitumor AssaysABSTRACT
IQGAP1 is a scaffold protein involved in a range of cellular activities, including migration, invasion, adhesion and proliferation. It is also oncogenic in a variety of cancers, promoting primary tumor growth and invasiveness. However, the role of IQGAP1 in tumor progression and metastasis remains unclear. In this study, we use both knockdown and knockout of IQGAP1 to investigate its role in the metastatic cascade of both melanoma and breast cancer cells in vivo. We find that reduction of IQGAP1 expression decreases the formation of both spontaneous and experimental metastases, without limiting primary or metastatic tumor growth. Furthermore, IQGAP1 knockout significantly inhibits extravasation of tumor cells from circulation, possibly involving invadopodial function. By expressing mutant forms of IQGAP1 in a knockout context, we also determine that IQGAP1's pro-metastatic functions are dependent on multiple domains and functions. These data demonstrate that IQGAP1 is crucial for metastasis in vivo through regulation of extravasation and suggest that it may represent a valid therapeutic target for inhibiting metastasis.
Subject(s)
Breast Neoplasms/genetics , Melanoma/genetics , Neoplasm Invasiveness/genetics , ras GTPase-Activating Proteins/genetics , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Movement , Female , Gene Expression Regulation, Neoplastic , Gene Knockdown Techniques , Gene Knockout Techniques , Humans , Melanoma/pathology , Neoplasm Invasiveness/pathology , Neoplasm Metastasis/genetics , Neoplasm Metastasis/pathologyABSTRACT
Adam13/33 is a cell surface metalloprotease critical for cranial neural crest (CNC) cell migration. It can cleave multiple substrates including itself, fibronectin, ephrinB, cadherin-11, pcdh8 and pcdh8l (this work). Cleavage of cadherin-11 produces an extracellular fragment that promotes CNC migration. In addition, the adam13 cytoplasmic domain is cleaved by gamma secretase, translocates into the nucleus and regulates multiple genes. Here, we show that adam13 interacts with the arid3a/dril1/Bright transcription factor. This interaction promotes a proteolytic cleavage of arid3a and its translocation to the nucleus where it regulates another transcription factor: tfap2α. Tfap2α in turn activates multiple genes including the protocadherin pcdh8l (PCNS). The proteolytic activity of adam13 is critical for the release of arid3a from the plasma membrane while the cytoplasmic domain appears critical for the cleavage of arid3a. In addition to this transcriptional control of pcdh8l, adam13 cleaves pcdh8l generating an extracellular fragment that also regulates cell migration.
Subject(s)
ADAM Proteins/metabolism , Cadherins/metabolism , DNA-Binding Proteins/metabolism , Gene Expression Regulation , Membrane Proteins/metabolism , Neural Crest/physiology , Transcription Factor AP-2/metabolism , Transcription Factors/metabolism , Xenopus Proteins/metabolism , Animals , Protocadherins , Transcription, Genetic , Xenopus laevisABSTRACT
Cadherin receptors have a well-established role in cell-cell adhesion, cell polarization and differentiation. However, some cadherins also promote cell and tissue movement during embryonic development and tumour progression. In particular, cadherin-11 is upregulated during tumour and inflammatory cell invasion, but the mechanisms underlying cadherin-11 stimulated cell migration are still incompletely understood. Here, we show that cadherin-11 localizes to focal adhesions and promotes adhesion to fibronectin in Xenopus neural crest, a highly migratory embryonic cell population. Transfected cadherin-11 also localizes to focal adhesions in different mammalian cell lines, while endogenous cadherin-11 shows focal adhesion localization in primary human fibroblasts. In focal adhesions, cadherin-11 co-localizes with ß1-integrin and paxillin and physically interacts with the fibronectin-binding proteoglycan syndecan-4. Adhesion to fibronectin mediated by cadherin-11/syndecan-4 complexes requires both the extracellular domain of syndecan-4, and the transmembrane and cytoplasmic domains of cadherin-11. These results reveal an unexpected role of a classical cadherin in cell-matrix adhesion during cell migration.
Subject(s)
Cadherins/metabolism , Cell Adhesion , Cells/cytology , Focal Adhesions/metabolism , Xenopus laevis/metabolism , Animals , Cadherins/genetics , Cell Line , Cell Movement , Cells/metabolism , Fibronectins/metabolism , Focal Adhesions/genetics , Humans , Mice , Neural Crest/growth & development , Neural Crest/metabolism , Protein Transport , Xenopus laevis/embryology , Xenopus laevis/geneticsABSTRACT
The cranial neural crest (CNC) is a highly motile population of cells that is responsible for forming the face and jaw in all vertebrates and perturbing their migration can lead to craniofacial birth defects. Cell motility requires a dynamic modification of cell-cell and cell-matrix adhesion. In the CNC, cleavage of the cell adhesion molecule cadherin-11 by ADAM13 is essential for cell migration. This cleavage generates a shed extracellular fragment of cadherin-11 (EC1-3) that possesses pro-migratory activity via an unknown mechanism. Cadherin-11 plays an important role in modulating contact inhibition of locomotion (CIL) in the CNC to regulate directional cell migration. Here, we show that while the integral cadherin-11 requires the homophilic binding site to promote CNC migration in vivo, the EC1-3 fragment does not. In addition, we show that increased ADAM13 activity or expression of the EC1-3 fragment increases CNC invasiveness in vitro and blocks the repulsive CIL response in colliding cells. This activity requires the presence of an intact homophilic binding site on the EC1-3 suggesting that the cleavage fragment may function as a competitive inhibitor of cadherin-11 adhesion in CIL but not to promote cell migration in vivo.
Subject(s)
ADAM Proteins/metabolism , Membrane Proteins/metabolism , Neural Crest/cytology , Xenopus Proteins/metabolism , Animals , Binding Sites , COS Cells , Cadherins/genetics , Cadherins/metabolism , Cell Adhesion , Cell Movement/drug effects , Chlorocebus aethiops , Codon, Nonsense , Hydrophobic and Hydrophilic Interactions , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Organ Culture Techniques , Peptide Fragments/pharmacology , Peptide Fragments/physiology , Protein Binding , Protein Processing, Post-Translational , Recombinant Proteins/metabolism , Structure-Activity Relationship , Transfection , Xenopus Proteins/genetics , Xenopus laevis/embryologyABSTRACT
Cranial neural crest (CNC) cells are a transient population of stem cells that originate at the border of the neural plate and the epidermis, and migrate ventrally to contribute to most of the facial structures including bones, cartilage, muscles and ganglia. ADAM13 is a cell surface metalloprotease that is essential for CNC cell migration. Here, we show in Xenopus laevis embryos that the Wnt receptor Fz4 binds to the cysteine-rich domain of ADAM13 and negatively regulates its proteolytic activity in vivo. Gain of Fz4 function inhibits CNC cell migration and can be rescued by gain of ADAM13 function. Loss of Fz4 function also inhibits CNC cell migration and induces a reduction of mature ADAM13, together with an increase in the ADAM13 cytoplasmic fragment that is known to translocate into the nucleus to regulate gene expression. We propose that Fz4 associates with ADAM13 during its transport to the plasma membrane to regulate its proteolytic activity.
Subject(s)
ADAM Proteins/metabolism , Embryo, Nonmammalian/metabolism , Frizzled Receptors/metabolism , Gene Expression Regulation, Developmental , Membrane Proteins/metabolism , Neural Crest/metabolism , Wnt Proteins/metabolism , Xenopus Proteins/metabolism , ADAM Proteins/genetics , Animals , COS Cells , Cell Membrane/metabolism , Cell Movement , Cell Nucleus/metabolism , Cell Proliferation , Cells, Cultured , Chlorocebus aethiops , Embryo, Nonmammalian/cytology , Fluorescent Antibody Technique , Frizzled Receptors/genetics , HEK293 Cells , Humans , Immunoprecipitation , In Situ Hybridization , Membrane Proteins/genetics , Neural Crest/cytology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Wnt Proteins/genetics , Xenopus Proteins/genetics , Xenopus laevis/genetics , Xenopus laevis/growth & development , Xenopus laevis/metabolismABSTRACT
ADAMs are cell surface metalloproteases that control multiple biological processes by cleaving signaling and adhesion molecules. ADAM13 controls cranial neural crest (CNC) cell migration both by cleaving cadherin-11 to release a promigratory extracellular fragment and by controlling expression of multiple genes via its cytoplasmic domain. The latter activity is regulated by γ-secretase cleavage and the translocation of the cytoplasmic domain into the nucleus. One of the genes regulated by ADAM13, the protease calpain8, is essential for CNC migration. Although the nuclear function of ADAM13 is evolutionarily conserved, it is unclear whether the transcriptional regulation is also performed by other ADAMs and how this process may be regulated. We show that ADAM13 function to promote CNC migration is regulated by two phosphorylation events involving GSK3 and Polo-like kinase (Plk). We further show that inhibition of either kinase blocks CNC migration and that the respective phosphomimetic forms of ADAM13 can rescue these inhibitions. However, these phosphorylations are not required for ADAM13 proteolysis of its substrates, γ-secretase cleavage, or nuclear translocation of its cytoplasmic domain. Of significance, migration of the CNC can be restored in the absence of Plk phosphorylation by expression of calpain-8a, pointing to impaired nuclear activity of ADAM13.
Subject(s)
ADAM Proteins/metabolism , Cell Cycle Proteins/physiology , Glycogen Synthase Kinase 3/physiology , Membrane Proteins/metabolism , Neural Crest/physiology , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins/physiology , Xenopus Proteins/metabolism , Xenopus Proteins/physiology , Animals , Cell Movement , Cell Nucleus/enzymology , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/enzymology , HEK293 Cells , Humans , Phosphorylation , Protein Processing, Post-Translational , Proteolysis , Xenopus laevis/embryology , Xenopus laevis/metabolism , Polo-Like Kinase 1ABSTRACT
The cranial neural crest (CNC) is a population of cells that arises from the lateral part of the developing brain, migrates ventrally and coordinates the entire craniofacial development of vertebrates. Many molecules are involved in CNC migration including the transmembrane metalloproteases ADAM13 and 19. We have previously shown that these ADAMs cleave a number of extracellular proteins and modify the transcription of a number of genes, and that both of these activities are important for cell migration. Here we show that the knock down of ADAM13 inhibits CNC migration in vivo but not in vitro, indicating that ADAM13 function is required in the 3-dimentional context of the embryo. We further show that the migration of CNC that do not express ADAM13 and ADAM19 can be rescued in vivo by co-grafting wild type CNC. Furthermore, the migration of CNC lacking ADAM13 can be rescued by mechanically separating the CNC from the surrounding ectoderm and mesoderm. Finally, we show that ADAM13 function is autonomous to CNC tissue, as the migration of morphant CNC can only be rescued by ADAM13 expression in the CNC and not the surrounding tissues. Together our results suggest that ADAM13 changes CNC interaction with the extracellular environment and that this change is necessary for their migration in vivo.
Subject(s)
ADAM Proteins/metabolism , Cell Movement , Embryo, Nonmammalian/metabolism , Membrane Proteins/metabolism , Neural Crest/metabolism , Xenopus Proteins/metabolism , Xenopus laevis/metabolism , ADAM Proteins/genetics , Animals , Cell Transplantation/methods , Ectoderm/cytology , Ectoderm/embryology , Ectoderm/metabolism , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/embryology , Gene Knockdown Techniques , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Membrane Proteins/genetics , Mesoderm/cytology , Mesoderm/embryology , Mesoderm/metabolism , Microscopy, Fluorescence , Neural Crest/cytology , Neural Crest/embryology , Skull/cytology , Time Factors , Time-Lapse Imaging , Xenopus Proteins/genetics , Xenopus laevis/embryology , Xenopus laevis/geneticsABSTRACT
Fluorescent proteins have revolutionized modern biology with their ability to report the presence of tagged proteins in living systems. Although several fluorescent proteins have been described in which the excitation and emission properties can be modulated by external triggers, no fluorescent proteins have been described that can be activated from a silent dark state to a bright fluorescent state directly by the activity of an enzyme. We have developed a version of GFP in which fluorescence is completely quenched by appendage of a hydrophobic quenching peptide that tetramerizes GFP and prevents maturation of the chromophore. The fluorescence can be fully restored by catalytic removal of the quenching peptide, making it a robust reporter of proteolysis. We have demonstrated the utility of this uniquely dark state of GFP as a genetically encoded apoptosis reporter that monitors the function of caspases, which catalyze the fate-determining step in programmed cell death. Caspase Activatable-GFP (CA-GFP) can be activated both in vitro and in vivo, resulting in up to a 45-fold increase in fluorescent signal in bacteria and a 3-fold increase in mammalian cells. We used CA-GFP successfully to monitor real-time apoptosis in mammalian cells. This dark state of GFP may ultimately serve as a useful platform for probes of other enzymatic processes.
Subject(s)
Apoptosis , Caspases/metabolism , Genes, Reporter , Green Fluorescent Proteins/metabolism , Proteolysis , Animals , Caspases/genetics , Catalysis , Green Fluorescent Proteins/genetics , Mice , Microscopy, Fluorescence/methods , NIH 3T3 CellsABSTRACT
ADAMs are transmembrane metalloproteases that control cell behavior by cleaving both cell adhesion and signaling molecules. The cytoplasmic domain of ADAMs can regulate the proteolytic activity by controlling the subcellular localization and/or the activation of the protease domain. Here, we show that the cytoplasmic domain of ADAM13 is cleaved and translocates into the nucleus. Preventing this translocation renders the protein incapable of promoting cranial neural crest (CNC) cell migration in vivo, without affecting its proteolytic activity. In addition, the cytoplasmic domain of ADAM13 regulates the expression of multiple genes in CNC, including the protease Calpain8-a. Restoring the expression of Calpain8-a is sufficient to rescue CNC migration in the absence of the ADAM13 cytoplasmic domain. This study shows that the cytoplasmic domain of ADAM metalloproteases can perform essential functions in the nucleus of cells and may contribute substantially to the overall function of the protein.
Subject(s)
ADAM Proteins/chemistry , ADAM Proteins/metabolism , Calpain/metabolism , Cell Movement , Cell Nucleus/metabolism , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Neural Crest/cytology , Skull/cytology , Xenopus Proteins/metabolism , Amyloid Precursor Protein Secretases/metabolism , Animals , Cell Line , Conserved Sequence/genetics , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/metabolism , Evolution, Molecular , Gene Expression Regulation, Developmental , Humans , Neural Crest/metabolism , Protein Structure, Tertiary , Protein Transport , Structure-Activity Relationship , Xenopus Proteins/chemistry , Xenopus laevis/embryology , Xenopus laevis/geneticsABSTRACT
Caspase-6 is an apoptotic cysteine protease that also governs disease progression in Huntington's and Alzheimer's diseases. Caspase-6 is of great interest as a target for treatment of these neurodegenerative diseases; however, the molecular basis of caspase-6 function and regulation remains poorly understood. In the recently reported structure of caspase-6, the 60's and 130's helices at the base of the substrate-binding groove extend upward, in a conformation entirely different from that of any other caspase. Presently, the central question about caspase-6 structure and function is whether the extended conformation is the catalytically competent conformation or whether the extended helices must undergo a large conformational rearrangement in order to bind substrate. We have generated a series of caspase-6 cleavage variants, including a novel constitutively two-chain form, and determined crystal structures of caspase-6 with and without the intersubunit linker. This series allows evaluation of the role of the prodomain and intersubunit linker on caspase-6 structure and function before and after substrate binding. Caspase-6 is inherently more stable than closely related caspases. Cleaved caspase-6 with both the prodomain and the linker present is the most stable, indicating that these two regions act in concert to increase stability, but maintain the extended conformation in the unliganded state. Moreover, these data suggest that caspase-6 undergoes a significant conformational change upon substrate binding, adopting a structure that is more like canonical caspases.